These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 18357775)

  • 21. The role of sensitized T-cells in myocarditis and dilated cardiomyopathy.
    Schwimmbeck PL; Badorff C; Rohn G; Schulze K; Schultheiss HP
    Int J Cardiol; 1996 May; 54(2):117-25. PubMed ID: 8803675
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
    J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional Consequences of RNA 5'-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation.
    Lévêque N; Garcia M; Bouin A; Nguyen JHC; Tran GP; Andreoletti L; Semler BL
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28539455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease.
    Liu P; Aitken K; Kong YY; Opavsky MA; Martino T; Dawood F; Wen WH; Kozieradzki I; Bachmaier K; Straus D; Mak TW; Penninger JM
    Nat Med; 2000 Apr; 6(4):429-34. PubMed ID: 10742150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms and consequences of enterovirus persistence in cardiac myocytes and cells of the immune system.
    Kandolf R; Sauter M; Aepinus C; Schnorr JJ; Selinka HC; Klingel K
    Virus Res; 1999 Aug; 62(2):149-58. PubMed ID: 10507324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on the survival of mice with chronic ongoing myocarditis caused by Coxsackievirus B3.
    Seko Y; Takahashi N; Yagita H; Okumura K; Azuma M; Yazaki Y
    J Pathol; 1999 May; 188(1):107-12. PubMed ID: 10398149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy.
    Wessely R; Klingel K; Santana LF; Dalton N; Hongo M; Jonathan Lederer W; Kandolf R; Knowlton KU
    J Clin Invest; 1998 Oct; 102(7):1444-53. PubMed ID: 9769337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of B lymphocytes in coxsackievirus B3 infection.
    Mena I; Perry CM; Harkins S; Rodriguez F; Gebhard J; Whitton JL
    Am J Pathol; 1999 Oct; 155(4):1205-15. PubMed ID: 10514403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmunity in coxsackievirus infection.
    Rose NR
    Curr Top Microbiol Immunol; 2008; 323():293-314. PubMed ID: 18357776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis.
    Guo Y; Wu W; Cen Z; Li X; Kong Q; Zhou Q
    Virol J; 2014 Dec; 11():230. PubMed ID: 25547181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological and pathological consequences of coxsackievirus RNA persistence in the heart.
    Flynn CT; Kimura T; Frimpong-Boateng K; Harkins S; Whitton JL
    Virology; 2017 Dec; 512():104-112. PubMed ID: 28950225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular pathology and structural features of enteroviral replication. Toward understanding the pathogenesis of viral heart disease.
    Klingel K; Selinka HC; Huber M; Sauter M; Leube M; Kandolf R
    Herz; 2000 May; 25(3):216-20. PubMed ID: 10904841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy.
    Gorbea C; Makar KA; Pauschinger M; Pratt G; Bersola JL; Varela J; David RM; Banks L; Huang CH; Li H; Schultheiss HP; Towbin JA; Vallejo JG; Bowles NE
    J Biol Chem; 2010 Jul; 285(30):23208-23. PubMed ID: 20472559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis.
    Corsten MF; Heggermont W; Papageorgiou AP; Deckx S; Tijsma A; Verhesen W; van Leeuwen R; Carai P; Thibaut HJ; Custers K; Summer G; Hazebroek M; Verheyen F; Neyts J; Schroen B; Heymans S
    Eur Heart J; 2015 Nov; 36(42):2909-19. PubMed ID: 26206211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative analysis of viral RNA kinetics in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease.
    Reetoo KN; Osman SA; Illavia SJ; Cameron-Wilson CL; Banatvala JE; Muir P
    J Gen Virol; 2000 Nov; 81(Pt 11):2755-2762. PubMed ID: 11038389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idiopathic dilated cardiomyopathy as a late complication of healed viral (Coxsackie B virus) myocarditis: historical analysis, review of the literature, and a postulated unifying hypothesis.
    Spotnitz MD; Lesch M
    Prog Cardiovasc Dis; 2006; 49(1):42-57. PubMed ID: 16867849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manipulating intestinal immunity and microflora: an alternative solution to viral myocarditis?
    Qian Q; Xiong S; Xu W
    Future Microbiol; 2012 Oct; 7(10):1207-16. PubMed ID: 23030425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy.
    Muir P; Nicholson F; Illavia SJ; McNeil TS; Ajetunmobi JF; Dunn H; Starkey WG; Reetoo KN; Cary NR; Parameshwar J; Banatvala JE
    Heart; 1996 Sep; 76(3):243-9. PubMed ID: 8868984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.